Exercise is one of the most widely recommended approaches for knee osteoarthritis, and a large Cochrane systematic review set out to test how well it actually works. The review pooled data from about 139 clinical trials involving roughly 12,468 people, comparing land-based therapeutic exercise programs — such as strengthening, flexibility, or aerobic activity done on land rather than in water — against no exercise or usual care.
What the research looked at
The reviewers combined results across this large group of trials to see whether land-based therapeutic exercise changes pain, physical function, and quality of life for people with knee osteoarthritis, both immediately after a course of treatment and further out, at 2 to 6 months later. Pooling so many studies gives a more stable picture than any single trial could, though it also means the trials varied in the type, dose, and setting of exercise used.
What it found
Across the pooled data, land-based therapeutic exercise probably improves pain, physical function, and quality of life in the short term for people with knee osteoarthritis. Immediately after treatment, participants who exercised showed reduced pain of about 12 points on a 0-100 scale and improved physical function of about 10 points, compared with those who did not exercise. These benefits did not disappear right away: smaller but still measurable improvements — about 6 points for pain and 3 points for function — were present 2 to 6 months after the exercise program ended.
What it means (and the limits)
The certainty of this evidence was rated low to moderate, and most of the underlying trials were unblinded — meaning participants and often their therapists knew who was exercising and who was not, which can inflate reported benefits. Because of this, the real-world effect of exercise for any one person may be more modest than the pooled numbers suggest, and the size of the benefit also appears to fade somewhat over the months after treatment. Even with these limitations, exercise carries low risk and consistent signals of benefit across a very large evidence base, which is why it continues to be recommended as a first-line treatment for knee osteoarthritis. It is not a cure, and it works best as part of an ongoing routine rather than a one-time fix.
Sources: https://pubmed.ncbi.nlm.nih.gov/26405113/ · https://www.cochrane.org/evidence/CD004376_exercise-effective-therapy-treat-knee-osteoarthritis
Dual-action joint collagen
Mafsal Riyadi combines the two collagen types most studied for joints — high-tripeptide hydrolyzed collagen and undenatured type II collagen — in one licensed dietary supplement (EDA reg. no. 14711/2026). Research about ingredient categories is general and is not a claim about any individual product.
Learn about Mafsal RiyadiThis is a plain-language summary of published research for general education. It is not medical advice, a diagnosis, or a treatment recommendation, and individual studies have limitations. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Consult your doctor or pharmacist about your own situation.
